BioXcel presents at-home agitation trial data at medical meeting

May 28, 2026 7:00 AM

BioXcel Therapeutics Inc. (NASDAQ: BTAI) presented new data from its Phase 3 SERENITY At-Home trial at the American Society of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found